Political uncertainty in Thailand will limit investment growth, but pharma market to see 7% CAGR grow

Thailand has retained 10th position out of the 17 markets surveyed in the Asia Pacific region, just above the Philippines, according to Business Monitor International’s Pharmaceutical Business Environment Ratings for first-quarter 2011.

The country’s score has, however, decreased marginally, from 52.6 to 51.1, due to a perceived worsening of its Rewards rating. Nevertheless, Thailand appeals to bold investors because it ranks higher according to Rewards compared with the standard Risk/Reward composite, although BMI expects investment inflows to be negatively affected over the medium to longer term by the unstable political situation. Globally, Thailand ranks 43rd, out of 83 markets surveyed.

$3.76 drugs market in 2009